Procedure Overview: Transurethral resection of a bladder tumor (TURBT) is a surgical procedure to remove bladder tumors through the urethra.
Primary Purpose: It serves both as a diagnostic tool (to obtain tissue for biopsy) and a therapeutic intervention (to remove visible tumors).
Anesthesia: Typically performed under general or spinal anesthesia, ensuring patient comfort and immobility during the procedure.
Minimally Invasive: As it's performed endoscopically through the natural opening of the urethra, it avoids external incisions.
Post-Procedure Catheter: A urinary catheter is often placed temporarily after the procedure to drain the bladder and facilitate healing.
🤒 Associated Symptoms
Hematuria: Presence of blood in the urine, which can be visible (gross hematuria) or microscopic, is the most common presenting symptom.
Dysuria: Pain or discomfort during urination, often described as a burning sensation.
Urinary Frequency and Urgency: An increased need to ur urinate more often than usual, sometimes with a sudden, strong urge.
Recurrent Urinary Tract Infections (UTIs): Bladder irritation caused by tumors can mimic or predispose individuals to frequent UTIs.
Pelvic Pain: While less common, persistent discomfort or pain in the lower abdomen or pelvic region may occur, especially with larger tumors.
🛡 Crucial Precautions
Anticoagulant Management: Patients on blood thinners (e.g., warfarin, aspirin, novel oral anticoagulants) must discuss medication cessation with their physician well in advance of the procedure to minimize bleeding risk.
NPO Status: Strict adherence to nothing by mouth (NPO) guidelines for food and drink for a specified period before surgery is critical to prevent aspiration.
Allergy Disclosure: Inform the medical team of all known allergies, including medications, latex, and any previous reactions to anesthesia.
Infection Prevention: Prophylactic antibiotics may be administered before the procedure to reduce the risk of post-operative infection.
Post-operative Bleeding Monitoring: Closely observe urine color post-procedure; pink or light red urine is common, but bright red urine with clots requires immediate medical attention.
Bladder Perforation Awareness: Although rare, severe abdominal pain or distension post-TURBT could indicate bladder perforation and warrants urgent evaluation.
🍽 Dietary Directions & Restrictions
Pre-Procedure Fasting: Adhere strictly to NPO instructions, typically no solid food for 6-8 hours and no clear liquids for 2 hours prior to surgery.
Post-Procedure Hydration: Encourage increased oral fluid intake (water, clear broths) once cleared by medical staff to help flush the bladder and prevent clot formation.
Avoid Bladder Irritants: For several weeks post-procedure, advise avoiding bladder irritants such as caffeine, alcohol, spicy foods, and acidic juices to minimize discomfort and promote healing.
Fiber-Rich Diet: Promote a diet rich in fiber to prevent constipation, as straining during bowel movements can put pressure on the healing bladder.
Gradual Reintroduction: Start with light, easily digestible foods post-anesthesia and gradually return to a regular diet as tolerated.
⚠️ Attendant Guidelines
Transportation Arrangement: Ensure reliable transportation home is arranged, as the patient will not be permitted to drive after receiving anesthesia.
Post-Operative Observation: Assist in monitoring for signs of complications such as excessive bleeding (bright red urine with clots), inability to urinate, or severe abdominal pain.
Activity Restrictions Enforcement: Help the patient adhere to post-operative restrictions, including avoiding heavy lifting, strenuous activities, and sexual intercourse for the recommended period.
Medication Adherence: Ensure the patient takes prescribed pain relievers and antibiotics as directed to manage discomfort and prevent infection.
Emergency Contact Preparedness: Be aware of who to contact (e.g., urologist's office, emergency services) if urgent concerns arise post-discharge.
🩺 Physician's Perspective
Crucial for Staging: TURBT is fundamental for accurately staging bladder cancer, differentiating between non-muscle invasive and muscle-invasive disease, which dictates subsequent treatment.
Recurrence Risk: Emphasize the high recurrence rate of bladder cancer, necessitating diligent follow-up with regular cystoscopies and surveillance protocols.
Adjuvant Therapy Consideration: For high-risk non-muscle invasive bladder cancer, intravesical chemotherapy (e.g., Mitomycin C) or immunotherapy (e.g., BCG) may be recommended post-TURBT to reduce recurrence.
Smoking Cessation: Strongly advise smoking cessation, as it is the most significant modifiable risk factor for bladder cancer development and recurrence.
Multidisciplinary Approach: Stress the importance of a multidisciplinary team approach for complex cases, involving urologists, oncologists, and pathologists.
🎓 Academic & Nursing Corner
Pre-operative Education: Provide comprehensive patient education regarding the procedure, expected post-operative course, and potential complications.
Catheter Care Management: Competently manage indwelling urinary catheters, including continuous bladder irrigation (CBI) if ordered, to prevent clot formation and maintain patency.
Pain Assessment and Management: Regularly assess pain levels using appropriate scales and administer prescribed analgesia effectively.
Fluid Balance Monitoring: Accurately monitor and document intake and output, especially crucial with CBI, to assess for fluid overload or inadequate drainage.
Discharge Planning and Teaching: Educate patients and caregivers on wound care (if applicable), signs of infection, activity restrictions, medication schedules, and follow-up appointments.
🔬 Clinical Reference Index
Resectoscope: A specialized endoscope equipped with a light source, camera, and an electrical wire loop used for cutting and coagulating bladder tissue.
Electrocautery: The use of high-frequency electrical current to cut tissue and achieve hemostasis during the resection.
Continuous Bladder Irrigation (CBI): A post-operative procedure involving continuous infusion of sterile fluid into the bladder to prevent clot formation and maintain clear urine output.
Pathology Report: The definitive laboratory analysis of the resected tumor tissue, providing crucial information on tumor type, grade, depth of invasion, and presence of muscle.
Intravesical Therapy: Direct instillation of therapeutic agents (e.g., chemotherapy like Mitomycin C, immunotherapy like BCG) into the bladder post-TURBT to target residual cancer cells and reduce recurrence.